Neurology-Neuroimmunology Service, Multiple Sclerosis Center of Catalonia (Cemcat), Hospital Universitari Vall d'Hebron, Barcelona, Spain
 Research Article   
                                        
                                                                                Leishmaniasis in a Patient with Fingolimod-Treated Multiple Sclerosis: Infectious Challenges of Disease Modifying Therapies 
                                                                                Author(s): Lopez-Gonzalez A, Bosch-Nicolau P, Rodriguez-Acevedo B, Zabalza A, Sulleiro E, Aznar ML and Sanchez-Montalva A             
                                        
                                                                                
                                 In this report, we present a case of visceral leishmaniasis in a patient with multiple sclerosis (MS) under fingolimod treatment. We discuss the previously published cases of MS patients under different immunosuppressant therapies to highlight its risk in endemic areas and suggest a therapeutic approach... View More»
                                  
                                                                                DOI:
                                        10.35248/2376-0389.24.11.04.451